Updates from Phlow
Phlow and the United States Pharmacopeia have formed a strategic alliance to develop a new laboratory that will certify and validate Pharmaceutical Continuous Manufacturing processes resulting in affordable, high-quality, U.S.-manufactured essential medicines.
Business Wire | Feb. 22, 2021
This injection of additional strategic capital will further enhance Phlow’s mission to reimagine the end-to-end domestic production critical to U.S. healthcare.
Business Wire | Feb. 16, 2021
Phlow demonstrates a 100% U.S.-based and fully integrated solution that will have an extraordinary impact on the lives of patients and families for decades to come.
U.S. Representative Abigail Spanberger | Feb. 16, 2021
A unique partnership between Civica Rx, Phlow, VCU’s Medicines for All Institute, and AMPAC Fine Chemicals to ensure every American will have access to essential medicines.
Governor Ralph Northam | Jan. 21, 2021
Revolutionizing Pharma Manufacturing From The Outside In
Life Science Leader | Jan. 4, 2021
Stop Drug Shortages, Start Domestic Supply Chains
Outsourced Pharma | Nov. 10, 2020
Other News
Rosemary Gibson, author of “China Rx: Exposing the Risks of America’s Dependence on China for Medicine,” on why Medicare should require hospitals to buy American-made essential generic medications.
Inside Sources | Jan. 27, 2021
Inside the movement to put generic drug production back on America’s shores.
Pharma Manufacturing | Sept. 16, 2020
White Papers
Download Phlow’s White Paper on Addressing Essential Medicine Shortages